How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do?

被引:22
|
作者
Macleod, John [1 ]
Hickman, Matthew [1 ]
机构
[1] Univ Bristol, Dept Social Med, Bristol B58 2PS, Avon, England
基金
英国医学研究理事会;
关键词
Cannabis; evidence; public health; schizophrenia; CORONARY-HEART-DISEASE; STRESSFUL LIFE EVENTS; YOUNG-PEOPLE; PSYCHOTIC SYMPTOMS; ADULT PSYCHOSIS; SCHIZOPHRENIA; RISK; GENE; POPULATION; DEPRESSION;
D O I
10.1111/j.1360-0443.2009.02846.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
In the United Kingdom, as in many places, cannabis use is considered substantially within a criminal justice rather than a public health paradigm with prevention policy embodied in the Misuse of Drugs Act. In 2002 the maximum custodial sentence tariff for cannabis possession under the Act was reduced from 5 to 2 years. Vigorous and vociferous public debate followed this decision, centred principally on the question of whether cannabis use caused schizophrenia. It was suggested that new and compelling evidence supporting this hypothesis had emerged since the re-classification decision was made, meaning that the decision should be reconsidered. The re-classification decision was reversed in 2008. We consider whether the strength of evidence on the psychological harms of cannabis has changed substantially and discuss the factors that may have influenced recent public discourse and policy decisions. We also consider evidence for other harms of cannabis use and public health implications of preventing cannabis use. We conclude that the strongest evidence of a possible causal relation between cannabis use and schizophrenia emerged more than 20 years ago and that the strength of more recent evidence may have been overstated-for a number of possible reasons. We also conclude that cannabis use is almost certainly harmful, mainly because of its intimate relation to tobacco use. The most rational policy on cannabis from a public health perspective would seem to be one able to achieve the benefit of reduced use in the population while minimizing social and other costs of the policy itself. Prohibition, whatever the sentence tariff associated with it, seems unlikely to fulfil these criteria.
引用
收藏
页码:1326 / 1330
页数:5
相关论文
共 50 条
  • [31] HOW DO WE KNOW WHAT WE KNOW?
    Manton, Anne
    JOURNAL OF EMERGENCY NURSING, 2015, 41 (05) : 372 - 372
  • [32] How do we know what we know?
    Dhara, Arundhati
    CANADIAN FAMILY PHYSICIAN, 2021, 67 (11) : 851 - 852
  • [33] Governance: What Do We Know, and How Do We Know It?
    Fukuyama, Francis
    ANNUAL REVIEW OF POLITICAL SCIENCE, VOL 19, 2016, 19 : 89 - 105
  • [34] What do we know and how do we really know it?
    Pearce, JL
    ACADEMY OF MANAGEMENT REVIEW, 2004, 29 (02): : 175 - 179
  • [35] Polarization: What Do We Know and What Can We Do About It?
    Casal Bertoa, Fernando
    Rama, Jose
    FRONTIERS IN POLITICAL SCIENCE, 2021, 3
  • [36] LAETRILE - WHAT WE KNOW AND WHAT WE DO ABOUT IT
    JONES, GT
    ABRAMSON, N
    JOURNAL OF THE FLORIDA MEDICAL ASSOCIATION, 1979, 66 (05): : 548 - 552
  • [37] Arthritis in Canada: What do we know and what should we know?
    Badley, EM
    JOURNAL OF RHEUMATOLOGY, 2005, 32 : 39 - 41
  • [38] SOCIAL-STRATIFICATION - WHAT DO WE KNOW ABOUT IT, WHAT DO WE DO ABOUT IT
    OTNES, P
    TIDSSKRIFT FOR SAMFUNNSFORSKNING, 1986, 27 (04): : 312 - 333
  • [39] What do we know about why women bleed and what do we not know?
    James, Andra H.
    James, Paula D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (02) : 315 - 322
  • [40] Shorebirds ingest plastics too: what we know, what we do not know, and what we should do next
    Flemming, Scott A.
    Lanctot, Richard B.
    Price, Courtney
    Mallory, Mark L.
    Kuhn, Susanne
    Drever, Mark C.
    Barry, Tom
    Provencher, Jennifer F.
    ENVIRONMENTAL REVIEWS, 2022, 30 (04): : 537 - 551